Kathleen A. Rickard - Aug 1, 2021 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
Chief Medical Officer
Signature
/s/ Claire Poll, Attorney-in-fact for Kathleen Rickard
Stock symbol
VRNA
Transactions as of
Aug 1, 2021
Transactions value $
-$178,773
Form type
4
Date filed
8/3/2021, 10:00 PM
Next filing
Nov 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Tax liability -$179K -228K -7.42% $0.79* 2.84M Aug 1, 2021 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units.
F3 The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on July 30, 2021 divided by eight (8).
F4 Consists of (i) 2,300,360 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 287,545 ADSs); and (ii) 539,056 Ordinary Shares underlying 67,382 ADSs.